FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2246504185> ?p ?o ?g. }

• W2246504185 endingPage "13" @default.
• W2246504185 startingPage "508" @default.
• W2246504185 abstract "Multiple myeloma (MM) typically afflicts elderly patients. High-dose therapy has recently been shown to lead to a better outcome than standard treatment, mainly in younger patients. The extent to which older subjects can benefit from intensified approaches without excessive toxicity is examined in this study.Between December 1994 and May 1997, 12 Italian Multiple Myeloma Study Group institutions entered 68 patients at diagnosis (median age 65) into an intensified chemotherapy regimen: cyclophosphamide (CY) 3 g/m(2) plus melphalan 60 mg/m(2) followed by peripheral blood progenitor cells (PBPC) and G-CSF (CM regimen). CY (day 0) and G-CSF were used to mobilize PBPC harvested by a single leukapheresis on day 10. Melphalan was infused on day 11. PBPC were kept unprocessed at 4 degrees C for 48 hours and reinfused on day 12. Three CM regimens were delivered at 6-month intervals.Sufficient PBPC to support the first CM cycle were available (median CD34(+) harvest: 4.9x10(6)/kg), but dropped significantly after the second (median CD34(+) harvest: 2x10(6)/kg) and the third (median CD34(+) harvest: 0.9x10(6)/kg). The median durations of severe neutropenia (absolute neutrophil count < 500 microL) were 3, 4, and 3 days, and those of severe thrombocytopenia (platelets < 25,000/microL) were 2.5, 2, and 1 days, after the first, second and third courses, respectively. The frequency of extramedullary toxicities was low. Treatment-related mortality (TRM) was 3% after the first CM, only. Complete remission (CR) was 14% after the first, 16% after the second and 27% after the third CM. After a median follow-up of 34 months (range 19-49 months), median event-free survival was 35.6 months.These results indicate that dose-intensity of melphalan can be increased by reinfusing PBPC with acceptable low toxicity. The combination of CY and melphalan followed by PBPC is an effective chemotherapy for elderly myeloma patients. Repeated melphalan infusion hampered subsequent CD34(+) harvests." @default.
• W2246504185 created "2016-06-24" @default.
• W2246504185 creator A5011678278 @default.
• W2246504185 creator A5018139001 @default.
• W2246504185 creator A5020113695 @default.
• W2246504185 creator A5020164754 @default.
• W2246504185 creator A5027526895 @default.
• W2246504185 creator A5040555030 @default.
• W2246504185 creator A5044869604 @default.
• W2246504185 creator A5050615536 @default.
• W2246504185 creator A5053109309 @default.
• W2246504185 creator A5053536584 @default.
• W2246504185 creator A5058253118 @default.
• W2246504185 creator A5059967673 @default.
• W2246504185 creator A5066780948 @default.
• W2246504185 creator A5077270786 @default.
• W2246504185 creator A5079320603 @default.
• W2246504185 creator A5082191757 @default.
• W2246504185 date "2000-05-01" @default.
• W2246504185 modified "2023-10-02" @default.
• W2246504185 title "Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients." @default.
• W2246504185 cites W1233091556 @default.
• W2246504185 cites W1544278262 @default.
• W2246504185 cites W177396148 @default.
• W2246504185 cites W1791616244 @default.
• W2246504185 cites W1822308398 @default.
• W2246504185 cites W1870350942 @default.
• W2246504185 cites W1884458896 @default.
• W2246504185 cites W1931964440 @default.
• W2246504185 cites W195783192 @default.
• W2246504185 cites W1959587708 @default.
• W2246504185 cites W1964073968 @default.
• W2246504185 cites W1979300931 @default.
• W2246504185 cites W2006382315 @default.
• W2246504185 cites W2010977839 @default.
• W2246504185 cites W2013960033 @default.
• W2246504185 cites W202042235 @default.
• W2246504185 cites W2026295989 @default.
• W2246504185 cites W20342555 @default.
• W2246504185 cites W2063809730 @default.
• W2246504185 cites W2066777762 @default.
• W2246504185 cites W2072858641 @default.
• W2246504185 cites W2073172392 @default.
• W2246504185 cites W2095674485 @default.
• W2246504185 cites W2130358507 @default.
• W2246504185 cites W2152753334 @default.
• W2246504185 cites W2184746515 @default.
• W2246504185 cites W2265754523 @default.
• W2246504185 cites W2290337133 @default.
• W2246504185 cites W2404558869 @default.
• W2246504185 cites W2412808367 @default.
• W2246504185 cites W2413145428 @default.
• W2246504185 cites W2414573394 @default.
• W2246504185 cites W2416643931 @default.
• W2246504185 cites W2431119741 @default.
• W2246504185 cites W97946218 @default.
• W2246504185 cites W181450122 @default.
• W2246504185 cites W2333363976 @default.
• W2246504185 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10800168" @default.
• W2246504185 hasPublicationYear "2000" @default.
• W2246504185 type Work @default.
• W2246504185 sameAs 2246504185 @default.
• W2246504185 citedByCount "9" @default.
• W2246504185 crossrefType "journal-article" @default.
• W2246504185 hasAuthorship W2246504185A5011678278 @default.
• W2246504185 hasAuthorship W2246504185A5018139001 @default.
• W2246504185 hasAuthorship W2246504185A5020113695 @default.
• W2246504185 hasAuthorship W2246504185A5020164754 @default.
• W2246504185 hasAuthorship W2246504185A5027526895 @default.
• W2246504185 hasAuthorship W2246504185A5040555030 @default.
• W2246504185 hasAuthorship W2246504185A5044869604 @default.
• W2246504185 hasAuthorship W2246504185A5050615536 @default.
• W2246504185 hasAuthorship W2246504185A5053109309 @default.
• W2246504185 hasAuthorship W2246504185A5053536584 @default.
• W2246504185 hasAuthorship W2246504185A5058253118 @default.
• W2246504185 hasAuthorship W2246504185A5059967673 @default.
• W2246504185 hasAuthorship W2246504185A5066780948 @default.
• W2246504185 hasAuthorship W2246504185A5077270786 @default.
• W2246504185 hasAuthorship W2246504185A5079320603 @default.
• W2246504185 hasAuthorship W2246504185A5082191757 @default.
• W2246504185 hasConcept C10205521 @default.
• W2246504185 hasConcept C126322002 @default.
• W2246504185 hasConcept C126894567 @default.
• W2246504185 hasConcept C141071460 @default.
• W2246504185 hasConcept C2776364478 @default.
• W2246504185 hasConcept C2776689292 @default.
• W2246504185 hasConcept C2776694085 @default.
• W2246504185 hasConcept C2776755627 @default.
• W2246504185 hasConcept C2777063308 @default.
• W2246504185 hasConcept C2777371436 @default.
• W2246504185 hasConcept C2778684742 @default.
• W2246504185 hasConcept C2778850193 @default.
• W2246504185 hasConcept C2781413609 @default.
• W2246504185 hasConcept C28328180 @default.
• W2246504185 hasConcept C54355233 @default.
• W2246504185 hasConcept C71924100 @default.
• W2246504185 hasConcept C74133956 @default.
• W2246504185 hasConcept C86803240 @default.

• next